Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Determining when men need testosterone
The Clinical Advisor, 07/17/09
Quallich S - In middle-aged men, testosterone levels decrease 1%-2% yearly with advancing age. Studies suggest that approximately 20% of men in their 60s and 50% of those in their 80s have low serum testosterone levels. Obesity, metabolic syndrome, type 2 diabetes mellitus, and hypertension may increase the risk of hypogonadism. Men with symptomatic testosterone deficiency and a total testosterone level <300 may be candidates for testosterone replacement therapy, although no specific recommendations have been established. The typical treatment candidate has a validated low total testosterone level and consistent symptoms of testosterone deficiency, especially sexual function complaints. The benefits of testosterone therapy in men with testosterone deficiency include improvements in libido, sexual function, and quality of life; maintenance of cognitive function; prevention of bone mineral density (BMD) loss and osteoporosis; and possibly reductions in risk factors for cardiovascular disease. In older men with low-normal serum testosterone levels, recent evidence suggests that testosterone therapy increases lean body mass but has no beneficial effects on functional mobility, muscle strength, cognitive function, or BMD.
Today in Endocrine...keeping you current
Receive free subspecialty "5-minute updates" via email
A new FSHbeta mutation in a 29 year-old woman with primary amenorrhea and isolated FSH deficiency: functional characterization and ovarian response to human recombinant FSH
European Journal of Endocrinology, 12/18/09
Lower urinary tract symptoms, obesity and the metabolic syndrome
Current Opinion in Urology, 12/09/09
Kisspeptin/GPR54 system as potential target for endocrine disruption of reproductive development and function
International Journal of Andrology, 11/13/09
Article Search
Sponsor


See Latest Articles


